CN103893558A - Traditional Chinese medicine for treating leucoderma - Google Patents

Traditional Chinese medicine for treating leucoderma Download PDF

Info

Publication number
CN103893558A
CN103893558A CN201410094471.3A CN201410094471A CN103893558A CN 103893558 A CN103893558 A CN 103893558A CN 201410094471 A CN201410094471 A CN 201410094471A CN 103893558 A CN103893558 A CN 103893558A
Authority
CN
China
Prior art keywords
parts
radix
fructus
caulis spatholobi
chinese medicine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201410094471.3A
Other languages
Chinese (zh)
Inventor
于波
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN201410094471.3A priority Critical patent/CN103893558A/en
Publication of CN103893558A publication Critical patent/CN103893558A/en
Pending legal-status Critical Current

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

The invention discloses a traditional Chinese medicine for treating leucoderma, which is prepared from the following raw medicinal materials in parts by weight: 1-2 parts of schizonepeta, 1-2 parts of tribulus terrestris, 2-3 parts of caulis spatholobi, 1-2 parts of pillis ophidiae, 1-2 parts of jasminum subtriplinerve, 2-3 parts of rice-shell, 1-3 parts of viola arcuata, 2-4 parts of meadowrue root and rhizome, 2-4 parts of pulp of dogwood fruit, 1-5 parts of cockscomb, 1-4 parts of cortex acanthopanacis, 1-2 parts of lumbricus, 1-2 parts of umbilicaria esculenta, 2-4 parts of ground beeltle, 3-5 parts of radix clematidis, 8-10 parts of cortex dictamni, 14-16 parts of lithospermum, 4-6 parts of fructus psoraleae, 9-12 parts of smoked plum, 9-12 parts of caulis spatholobi, 9-12 parts of carcuma longa, 10-12 parts of sanguis draconis, 2-3 parts of muskone, and 9-12 parts of edible tulip.

Description

One is treated leukodermic Chinese medicine
Technical field
The present invention relates to treat the field of Chinese medicines, is exactly that one is treated leukodermic Chinese medicine.
Background technology
Vitiligo is a kind of common posteriority limit office property or general the de-disease of losing of property skin pigment.Cause because the melanocyte function of skin disappears, but mechanism is not clear.The each position of whole body can occur, and is common in and refers to that the back of the body, wrist, forearm, face, neck and genitals are etc. around.Female genitalia also can occur, and young women is in the majority.
Summary of the invention
The object of this invention is to provide one and treat leukodermic Chinese medicine.
The present invention adopts following technical scheme:
One is treated leukodermic Chinese medicine, it is characterized in that, it is to be made up of the crude drug of following weight portion: Herba Schizonepetae 1-2, Fructus Atriplicis Sibiricae 1-2, Caulis Spatholobi 2-3, Periostracum Serpentis 1-2, Jasminum nervosum Lour 1-2, olive 2-3, Viola arcuata 1-3, Radix et Rhizoma Thalictri 2-4, Fructus Corni 2-4, Flos Celosiae Cristatae 1-5, Cortex Acanthopancis 1-4, Pheretima 1-2, Umbillcaria esculenta 1-2, Eupolyphaga Seu Steleophaga 2-4, Radix Clematidis 3-5, Cortex Dictamni 8-10, Radix Arnebiae (Radix Lithospermi) 14-16, Fructus Psoraleae 4-6, Fructus Mume 9-12, Caulis Spatholobi 9-12, Rhizoma Curcumae Longae 9-12, the brown 10-12 of blood, artificial Moschus 2-3, Pseudobulbus Cremastrae Seu Pleiones 9-12.
The leukodermic Chinese medicine of described treatment, it is characterized in that: it is to be made up of the crude drug of following weight portion: Herba Schizonepetae 1, Fructus Atriplicis Sibiricae 2, Caulis Spatholobi 3, Periostracum Serpentis 1, Jasminum nervosum Lour 1, olive 3, Viola arcuata 1, Radix et Rhizoma Thalictri 4, Fructus Corni 2, Flos Celosiae Cristatae 1, Cortex Acanthopancis 1, Pheretima 2, Umbillcaria esculenta 2, Eupolyphaga Seu Steleophaga 2, Radix Clematidis 5, Cortex Dictamni 10, Radix Arnebiae (Radix Lithospermi) 16, Fructus Psoraleae 6, Fructus Mume 9, Caulis Spatholobi 12, Rhizoma Curcumae Longae 9, blood are brown 10, artificial Moschus 3, Pseudobulbus Cremastrae Seu Pleiones 12.
Beneficial effect of the present invention is:
The present invention's removing toxic substances, hyperchromic, cures mainly: vitiligo, white macula.
The specific embodiment
The leukodermic Chinese medicine of described treatment, it is to be made up of the crude drug of following weight (g): Herba Schizonepetae 1, Fructus Atriplicis Sibiricae 2, Caulis Spatholobi 3, Periostracum Serpentis 1, Jasminum nervosum Lour 1, olive 3, Viola arcuata 1, Radix et Rhizoma Thalictri 4, Fructus Corni 2, Flos Celosiae Cristatae 1, Cortex Acanthopancis 1, Pheretima 2, Umbillcaria esculenta 2, Eupolyphaga Seu Steleophaga 2, Radix Clematidis 5, Cortex Dictamni 10, Radix Arnebiae (Radix Lithospermi) 16, Fructus Psoraleae 6, Fructus Mume 9, Caulis Spatholobi 12, Rhizoma Curcumae Longae 9, blood are brown 10, artificial Moschus 3, Pseudobulbus Cremastrae Seu Pleiones 12.
Method for making usage: after above-mentioned all crude drug are mixed, with after 1.5 liters of soaking in Chinese liquor 6-8 days, get liquid and be coated with outward, once a day.
Function cures mainly: removing toxic substances, hyperchromic, cures mainly: vitiligo, white macula.
model case
Case 1: patient is permitted so-and-so, female, 18 years old, more than upper limb and cervical region occur that many places differ in size white macula half a year, give the present embodiment medicine affected part of exterior coating treatment recovery from illness after three months, follow up a case by regular visits to not recurrence in a year;
Case 2: patient Zhu, female, 52 years old, there is the white macula differing in size in back, buttocks both sides, and symmetrical, more than a year, gives the present embodiment medicine affected part of exterior coating treatment recovery from illness after five months, follows up a case by regular visits to not recurrence in a year;
Case 3, patient Liu so-and-so, female, 31 years old, in cervical region place and right side chest breast all have the white macula differing in size of dispersion, more than 2 years, give the present embodiment medicine affected part of exterior coating treatment recovery from illness after eight months, follow up a case by regular visits to not recurrence in a year;
Case 4, patient cattle so-and-so, man, 22 years old
There is the white macula differing in size in the both sides corners of the mouth, more than January, gives the present embodiment medicine affected part of exterior coating treatment recovery from illness after four months, follows up a case by regular visits to not recurrence in a year;
Case 5, patient Zhang, man, 17 years old
In the two cheekbones lamellar white macula that around differs in size, more than 3 years, give the present embodiment medicine affected part of exterior coating treatment recovery from illness after ten months, follow up a case by regular visits to not recurrence in a year.

Claims (2)

1. the leukodermic Chinese medicine for the treatment of, it is characterized in that, it is to be made up of the crude drug of following weight portion: Herba Schizonepetae 1-2, Fructus Atriplicis Sibiricae 1-2, Caulis Spatholobi 2-3, Periostracum Serpentis 1-2, Jasminum nervosum Lour 1-2, olive 2-3, Viola arcuata 1-3, Radix et Rhizoma Thalictri 2-4, Fructus Corni 2-4, Flos Celosiae Cristatae 1-5, Cortex Acanthopancis 1-4, Pheretima 1-2, Umbillcaria esculenta 1-2, Eupolyphaga Seu Steleophaga 2-4, Radix Clematidis 3-5, Cortex Dictamni 8-10, Radix Arnebiae (Radix Lithospermi) 14-16, Fructus Psoraleae 4-6, Fructus Mume 9-12, Caulis Spatholobi 9-12, Rhizoma Curcumae Longae 9-12, the brown 10-12 of blood, artificial Moschus 2-3, Pseudobulbus Cremastrae Seu Pleiones 9-12.
2. the leukodermic Chinese medicine for the treatment of according to claim 1, it is characterized in that: it is to be made up of the crude drug of following weight portion: Herba Schizonepetae 1, Fructus Atriplicis Sibiricae 2, Caulis Spatholobi 3, Periostracum Serpentis 1, Jasminum nervosum Lour 1, olive 3, Viola arcuata 1, Radix et Rhizoma Thalictri 4, Fructus Corni 2, Flos Celosiae Cristatae 1, Cortex Acanthopancis 1, Pheretima 2, Umbillcaria esculenta 2, Eupolyphaga Seu Steleophaga 2, Radix Clematidis 5, Cortex Dictamni 10, Radix Arnebiae (Radix Lithospermi) 16, Fructus Psoraleae 6, Fructus Mume 9, Caulis Spatholobi 12, Rhizoma Curcumae Longae 9, blood are brown 10, artificial Moschus 3, Pseudobulbus Cremastrae Seu Pleiones 12.
CN201410094471.3A 2014-03-14 2014-03-14 Traditional Chinese medicine for treating leucoderma Pending CN103893558A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201410094471.3A CN103893558A (en) 2014-03-14 2014-03-14 Traditional Chinese medicine for treating leucoderma

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201410094471.3A CN103893558A (en) 2014-03-14 2014-03-14 Traditional Chinese medicine for treating leucoderma

Publications (1)

Publication Number Publication Date
CN103893558A true CN103893558A (en) 2014-07-02

Family

ID=50985342

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201410094471.3A Pending CN103893558A (en) 2014-03-14 2014-03-14 Traditional Chinese medicine for treating leucoderma

Country Status (1)

Country Link
CN (1) CN103893558A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106038861A (en) * 2016-07-25 2016-10-26 陈凯 Chinese herbal medicine formula for treating leukoderma

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101406641A (en) * 2008-11-24 2009-04-15 黄玉英 Compound medicament for treating vitiligo
CN101757139A (en) * 2009-10-23 2010-06-30 成钢 Traditional Chinese medicine with magnetic nano elements of selenium, copper, and zinc for externally treating leucoderma
CN102038904A (en) * 2009-10-15 2011-05-04 张红旗 Chinese prescription for treating leucoderma
CN102430097A (en) * 2011-11-29 2012-05-02 渠淑敏 Chinese medicine for treating vitiligo
CN103251847A (en) * 2013-06-05 2013-08-21 高忠青 Traditional Chinese medicine for treating leucoderma

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101406641A (en) * 2008-11-24 2009-04-15 黄玉英 Compound medicament for treating vitiligo
CN102038904A (en) * 2009-10-15 2011-05-04 张红旗 Chinese prescription for treating leucoderma
CN101757139A (en) * 2009-10-23 2010-06-30 成钢 Traditional Chinese medicine with magnetic nano elements of selenium, copper, and zinc for externally treating leucoderma
CN102430097A (en) * 2011-11-29 2012-05-02 渠淑敏 Chinese medicine for treating vitiligo
CN103251847A (en) * 2013-06-05 2013-08-21 高忠青 Traditional Chinese medicine for treating leucoderma

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106038861A (en) * 2016-07-25 2016-10-26 陈凯 Chinese herbal medicine formula for treating leukoderma

Similar Documents

Publication Publication Date Title
CN103989818A (en) Medicinal liquor
CN103861046A (en) Traditional Chinese medicine for treating prosopalgia
CN104873898A (en) Preparation, namely blood conducting powder containing kudzuvine root and safflower, for treating hemiplegia
CN103028055B (en) Traditional Chinese medicine for treating migraine
CN103893558A (en) Traditional Chinese medicine for treating leucoderma
CN104815038B (en) A kind of external-applied ointment for acupuncture therapy
CN103341126B (en) Chinese medicine composite for treating chronic gastritis and preparation method thereof
CN102793904A (en) Preparation method for traditional Chinese medicine lotion for treatment of confusing-type closed fracture
CN105106837A (en) Traditional Chinese medicine combination for treating viral hepatitis
CN104288440A (en) Traditional Chinese medicine ointment for treating vitiligo
CN102961454A (en) Method for treating scapulohumeral periarthritis and preparation method for same
CN103191230A (en) Traditional Chinese medicine for treating infantile recurrent hordeolum
CN104510861A (en) Traditional Chinese medicine for treating rheumatoid disease
CN104825924A (en) Traditional Chinese medicine capable of promoting digestion and relieving stasis
CN105106706A (en) Externally-used liniment for treating allergic dermatitis
CN105233103A (en) Traditional Chinese medicine decoction for treating urinary tract infection
CN104922443A (en) External-use patch for treating rheumatic arthritis
CN104888039A (en) Traditional Chinese medicine capable of promoting digestion and relieving stasis
CN104474270A (en) Traditional Chinese medicine composition and application thereof
CN104001031A (en) Medicament for treating asthma
CN103285289A (en) Traditional Chinese medicine for treating arthralgia
CN103041218A (en) Traditional Chinese medicine composition for treating common cold
CN103933336A (en) Traditional Chinese medicine combination for treating leucoderma
CN104083645A (en) A traditional Chinese medicine composition treating postpartum body weakness dizziness
CN103239536A (en) Traditional Chinese medicine for treating influenza and preparation method thereof

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication
RJ01 Rejection of invention patent application after publication

Application publication date: 20140702